 1. Subjects with a medical condition that, in the Investigators opinion, could adversely impact the subjects participation, safety, or conduct of the study such as but not limited to a history of severe renal or hepatic impairment, severe active hepatic disease, or any other clinically significant medical condition that may preclude safe study participation. 